Trial intelligence / Profile preview

Prednisolone dosing for virus-induced facial palsy

jRCT1031190235Active, not recruiting

Sponsor
National Hospital Organization
Start
Mar 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised trial of prednisolone in facial palsy (2 arms), sponsored by National Hospital Organization. Primary endpoint: Recovery rate of facial palsy. Started Mar 2020; status: active, not recruiting.

02

Drugs

prednisolone
03

Conditions

facial palsy

Beyond the preview

Go deeper on jRCT1031190235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031190235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call